nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—Fluocinolone Acetonide—atopic dermatitis	0.582	0.833	CbGbCtD
Orlistat—CYP3A4—Pimecrolimus—atopic dermatitis	0.0301	0.0431	CbGbCtD
Orlistat—CYP3A4—Tacrolimus—atopic dermatitis	0.0179	0.0256	CbGbCtD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—FCER1A—atopic dermatitis	0.0141	0.155	CbGpPWpGaD
Orlistat—CYP3A4—Loratadine—atopic dermatitis	0.0131	0.0187	CbGbCtD
Orlistat—CYP3A4—Methylprednisolone—atopic dermatitis	0.012	0.0171	CbGbCtD
Orlistat—CYP3A4—Triamcinolone—atopic dermatitis	0.00907	0.013	CbGbCtD
Orlistat—CYP3A4—Betamethasone—atopic dermatitis	0.00779	0.0111	CbGbCtD
Orlistat—CYP3A4—Prednisolone—atopic dermatitis	0.00768	0.011	CbGbCtD
Orlistat—CYP3A4—Hydrocortisone—atopic dermatitis	0.00728	0.0104	CbGbCtD
Orlistat—CYP3A4—Prednisone—atopic dermatitis	0.00725	0.0104	CbGbCtD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—CCR3—atopic dermatitis	0.0069	0.0755	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—TLR2—atopic dermatitis	0.00546	0.0597	CbGpPWpGaD
Orlistat—CYP3A4—Dexamethasone—atopic dermatitis	0.00453	0.00649	CbGbCtD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IL18—atopic dermatitis	0.0042	0.0459	CbGpPWpGaD
Orlistat—PLA2G7—Peptide hormone metabolism—CMA1—atopic dermatitis	0.00308	0.0337	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IFNG—atopic dermatitis	0.00246	0.0269	CbGpPWpGaD
Orlistat—FASN—SREBF and miR33 in cholesterol and lipid homeostasis—PPARA—atopic dermatitis	0.00223	0.0244	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IL1B—atopic dermatitis	0.00219	0.024	CbGpPWpGaD
Orlistat—FASN—Sirolimus—Pimecrolimus—atopic dermatitis	0.0017	0.301	CbGdCrCtD
Orlistat—FASN—Sirolimus—Tacrolimus—atopic dermatitis	0.0017	0.301	CbGdCrCtD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—FCER1A—atopic dermatitis	0.00128	0.014	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MS4A2—atopic dermatitis	0.00119	0.013	CbGpPWpGaD
Orlistat—DAGLB—N-cadherin signaling events—MAPK8—atopic dermatitis	0.0011	0.0121	CbGpPWpGaD
Orlistat—DAGLA—N-cadherin signaling events—MAPK8—atopic dermatitis	0.0011	0.0121	CbGpPWpGaD
Orlistat—FASN—Activation of gene expression by SREBF (SREBP)—PPARA—atopic dermatitis	0.00107	0.0117	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—NPS—atopic dermatitis	0.000903	0.00988	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000903	0.00988	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000903	0.00988	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—NPS—atopic dermatitis	0.000903	0.00988	CbGpPWpGaD
Orlistat—FASN—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atopic dermatitis	0.000855	0.00936	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000807	0.00883	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000807	0.00883	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000807	0.00883	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000807	0.00883	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—GLB1—atopic dermatitis	0.000767	0.00839	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000734	0.00803	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000734	0.00803	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—KIF3A—atopic dermatitis	0.000619	0.00678	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—KIF3A—atopic dermatitis	0.000619	0.00678	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CMA1—atopic dermatitis	0.000581	0.00636	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000558	0.0061	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—SELE—atopic dermatitis	0.000499	0.00546	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—SELE—atopic dermatitis	0.000499	0.00546	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL22—atopic dermatitis	0.000499	0.00546	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL22—atopic dermatitis	0.000499	0.00546	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CCL27—atopic dermatitis	0.00049	0.00536	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CCL27—atopic dermatitis	0.00049	0.00536	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL27—atopic dermatitis	0.000445	0.00487	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL27—atopic dermatitis	0.000445	0.00487	CbGpPWpGaD
Orlistat—PLA2G4A—PDGF Pathway—NFKBIA—atopic dermatitis	0.000415	0.00454	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL17—atopic dermatitis	0.000399	0.00436	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL17—atopic dermatitis	0.000399	0.00436	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000395	0.00432	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—IL5—atopic dermatitis	0.000378	0.00414	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—IL5—atopic dermatitis	0.000378	0.00414	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000322	0.00352	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL11—atopic dermatitis	0.000321	0.00352	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL11—atopic dermatitis	0.000321	0.00352	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FCER2—atopic dermatitis	0.000317	0.00347	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FCER2—atopic dermatitis	0.000317	0.00347	CbGpPWpGaD
Orlistat—PNLIP—Disease—GLB1—atopic dermatitis	0.000297	0.00324	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL22—atopic dermatitis	0.000295	0.00322	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL22—atopic dermatitis	0.000295	0.00322	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CCR3—atopic dermatitis	0.000289	0.00316	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CCR3—atopic dermatitis	0.000289	0.00316	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.00028	0.00307	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.00028	0.00307	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—NFKBIA—atopic dermatitis	0.000272	0.00298	CbGpPWpGaD
Orlistat—PLA2G4A—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.000272	0.0479	CbGdCrCtD
Orlistat—DAGLB—Signaling Pathways—CCL27—atopic dermatitis	0.000263	0.00287	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL27—atopic dermatitis	0.000263	0.00287	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FCER2—atopic dermatitis	0.000263	0.00287	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCR3—atopic dermatitis	0.000262	0.00287	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCR3—atopic dermatitis	0.000262	0.00287	CbGpPWpGaD
Orlistat—PLA2G4A—PDGF Pathway—MAPK8—atopic dermatitis	0.00026	0.00285	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—TAC1—atopic dermatitis	0.000257	0.00281	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—TAC1—atopic dermatitis	0.000257	0.00281	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—NPS—atopic dermatitis	0.000257	0.00281	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—NPS—atopic dermatitis	0.000257	0.00281	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000252	0.00276	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000252	0.00276	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GLB1—atopic dermatitis	0.000248	0.00272	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—CASP8—atopic dermatitis	0.000246	0.00269	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL22—atopic dermatitis	0.000244	0.00267	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—IL5—atopic dermatitis	0.000239	0.00262	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—IL5—atopic dermatitis	0.000239	0.00262	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ADSL—atopic dermatitis	0.000238	0.0026	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL17—atopic dermatitis	0.000236	0.00258	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL17—atopic dermatitis	0.000236	0.00258	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—NPS—atopic dermatitis	0.000234	0.00256	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—NPS—atopic dermatitis	0.000234	0.00256	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—TAC1—atopic dermatitis	0.000234	0.00256	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—TAC1—atopic dermatitis	0.000234	0.00256	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCR3—atopic dermatitis	0.000229	0.00251	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCR3—atopic dermatitis	0.000229	0.00251	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL27—atopic dermatitis	0.000218	0.00238	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL5—atopic dermatitis	0.000217	0.00238	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL5—atopic dermatitis	0.000217	0.00238	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—KIF3A—atopic dermatitis	0.00021	0.0023	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—KIF3A—atopic dermatitis	0.00021	0.0023	CbGpPWpGaD
Orlistat—FASN—Disease—GLB1—atopic dermatitis	0.00021	0.0023	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000204	0.00223	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000204	0.00223	CbGpPWpGaD
Orlistat—PNLIP—Disease—SLC11A1—atopic dermatitis	0.000199	0.00217	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL17—atopic dermatitis	0.000195	0.00214	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CMA1—atopic dermatitis	0.00019	0.00208	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CMA1—atopic dermatitis	0.00019	0.00208	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL11—atopic dermatitis	0.00019	0.00208	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL11—atopic dermatitis	0.00019	0.00208	CbGpPWpGaD
Orlistat—PLA2G4A—Betamethasone—Desonide—atopic dermatitis	0.000186	0.0328	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Desonide—atopic dermatitis	0.000186	0.0328	CbGdCrCtD
Orlistat—DAGLB—Signaling by GPCR—CXCL10—atopic dermatitis	0.000185	0.00203	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL10—atopic dermatitis	0.000185	0.00203	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000185	0.00202	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK8—atopic dermatitis	0.000182	0.00199	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000181	0.00198	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—STAT6—atopic dermatitis	0.000179	0.00195	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—STAT6—atopic dermatitis	0.000179	0.00195	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—MAPK8—atopic dermatitis	0.000177	0.00194	CbGpPWpGaD
Orlistat—FASN—Metabolism—GLB1—atopic dermatitis	0.000176	0.00192	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CCL5—atopic dermatitis	0.000176	0.00192	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CCL5—atopic dermatitis	0.000176	0.00192	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—KIF3A—atopic dermatitis	0.000174	0.0019	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000171	0.00187	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000169	0.00185	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000169	0.00184	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000169	0.00184	CbGpPWpGaD
Orlistat—FASN—Metabolism—ADSL—atopic dermatitis	0.000168	0.00184	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL5—atopic dermatitis	0.000159	0.00174	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL5—atopic dermatitis	0.000159	0.00174	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000159	0.00174	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CCR5—atopic dermatitis	0.000158	0.00173	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CCR5—atopic dermatitis	0.000158	0.00173	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL11—atopic dermatitis	0.000157	0.00172	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CMA1—atopic dermatitis	0.000157	0.00172	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CXCL8—atopic dermatitis	0.000157	0.00172	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—KIF3A—atopic dermatitis	0.000156	0.00171	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCR3—atopic dermatitis	0.000155	0.00169	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCR3—atopic dermatitis	0.000155	0.00169	CbGpPWpGaD
Orlistat—PLA2G4A—Dexamethasone—Fluocinonide—atopic dermatitis	0.000149	0.0262	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Fluocinonide—atopic dermatitis	0.000149	0.0262	CbGdCrCtD
Orlistat—PNLIP—Signaling Pathways—STAT6—atopic dermatitis	0.000148	0.00162	CbGpPWpGaD
Orlistat—Mental disorder—Methylprednisolone—atopic dermatitis	0.000147	0.00072	CcSEcCtD
Orlistat—Malnutrition—Methylprednisolone—atopic dermatitis	0.000146	0.000716	CcSEcCtD
Orlistat—Asthenia—Tacrolimus—atopic dermatitis	0.000146	0.000715	CcSEcCtD
Orlistat—Angioedema—Prednisolone—atopic dermatitis	0.000146	0.000713	CcSEcCtD
Orlistat—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000145	0.000711	CcSEcCtD
Orlistat—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000145	0.000707	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000145	0.0255	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000145	0.0255	CbGdCrCtD
Orlistat—DAGLA—Hemostasis—IL2—atopic dermatitis	0.000145	0.00158	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—IL2—atopic dermatitis	0.000145	0.00158	CbGpPWpGaD
Orlistat—Pruritus—Tacrolimus—atopic dermatitis	0.000144	0.000705	CcSEcCtD
Orlistat—Malaise—Prednisolone—atopic dermatitis	0.000144	0.000703	CcSEcCtD
Orlistat—Dysgeusia—Triamcinolone—atopic dermatitis	0.000144	0.000702	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—CCR5—atopic dermatitis	0.000144	0.00157	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCR5—atopic dermatitis	0.000144	0.00157	CbGpPWpGaD
Orlistat—Vertigo—Prednisolone—atopic dermatitis	0.000143	0.000701	CcSEcCtD
Orlistat—Angioedema—Hydrocortisone—atopic dermatitis	0.000142	0.000696	CcSEcCtD
Orlistat—Back pain—Triamcinolone—atopic dermatitis	0.000142	0.000694	CcSEcCtD
Orlistat—Malaise—Hydrocortisone—atopic dermatitis	0.000141	0.000687	CcSEcCtD
Orlistat—FASN—Disease—SLC11A1—atopic dermatitis	0.000141	0.00154	CbGpPWpGaD
Orlistat—Vertigo—Hydrocortisone—atopic dermatitis	0.00014	0.000684	CcSEcCtD
Orlistat—Diarrhoea—Tacrolimus—atopic dermatitis	0.00014	0.000682	CcSEcCtD
Orlistat—Convulsion—Prednisolone—atopic dermatitis	0.000138	0.000676	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—NPS—atopic dermatitis	0.000138	0.00151	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TAC1—atopic dermatitis	0.000138	0.00151	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NPS—atopic dermatitis	0.000138	0.00151	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TAC1—atopic dermatitis	0.000138	0.00151	CbGpPWpGaD
Orlistat—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000136	0.000666	CcSEcCtD
Orlistat—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000136	0.000664	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—CXCR3—atopic dermatitis	0.000135	0.00148	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCR3—atopic dermatitis	0.000135	0.00148	CbGpPWpGaD
Orlistat—Alopecia—Betamethasone—atopic dermatitis	0.000135	0.000661	CcSEcCtD
Orlistat—Alopecia—Dexamethasone—atopic dermatitis	0.000135	0.000661	CcSEcCtD
Orlistat—Convulsion—Hydrocortisone—atopic dermatitis	0.000135	0.00066	CcSEcCtD
Orlistat—Dizziness—Tacrolimus—atopic dermatitis	0.000135	0.000659	CcSEcCtD
Orlistat—Discomfort—Prednisolone—atopic dermatitis	0.000134	0.000656	CcSEcCtD
Orlistat—Angioedema—Triamcinolone—atopic dermatitis	0.000134	0.000655	CcSEcCtD
Orlistat—Haemoglobin—Prednisone—atopic dermatitis	0.000134	0.000654	CcSEcCtD
Orlistat—Angioedema—Methylprednisolone—atopic dermatitis	0.000134	0.000654	CcSEcCtD
Orlistat—Haemorrhage—Prednisone—atopic dermatitis	0.000133	0.000651	CcSEcCtD
Orlistat—Myalgia—Hydrocortisone—atopic dermatitis	0.000133	0.000649	CcSEcCtD
Orlistat—Malaise—Triamcinolone—atopic dermatitis	0.000132	0.000647	CcSEcCtD
Orlistat—Anxiety—Hydrocortisone—atopic dermatitis	0.000132	0.000646	CcSEcCtD
Orlistat—Malaise—Methylprednisolone—atopic dermatitis	0.000132	0.000645	CcSEcCtD
Orlistat—Vertigo—Triamcinolone—atopic dermatitis	0.000132	0.000644	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000132	0.000644	CcSEcCtD
Orlistat—Vertigo—Methylprednisolone—atopic dermatitis	0.000132	0.000643	CcSEcCtD
Orlistat—Discomfort—Hydrocortisone—atopic dermatitis	0.000131	0.000641	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisolone—atopic dermatitis	0.00013	0.000637	CcSEcCtD
Orlistat—Oedema—Prednisolone—atopic dermatitis	0.00013	0.000637	CcSEcCtD
Orlistat—Vomiting—Tacrolimus—atopic dermatitis	0.00013	0.000634	CcSEcCtD
Orlistat—Rash—Tacrolimus—atopic dermatitis	0.000129	0.000628	CcSEcCtD
Orlistat—Dermatitis—Tacrolimus—atopic dermatitis	0.000128	0.000628	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CCR3—atopic dermatitis	0.000128	0.0014	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL5—atopic dermatitis	0.000128	0.0014	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL5—atopic dermatitis	0.000128	0.0014	CbGpPWpGaD
Orlistat—Cough—Triamcinolone—atopic dermatitis	0.000128	0.000626	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000128	0.0014	CbGpPWpGaD
Orlistat—Headache—Tacrolimus—atopic dermatitis	0.000128	0.000624	CcSEcCtD
Orlistat—Oedema—Hydrocortisone—atopic dermatitis	0.000127	0.000622	CcSEcCtD
Orlistat—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000127	0.000622	CcSEcCtD
Orlistat—Convulsion—Triamcinolone—atopic dermatitis	0.000127	0.000621	CcSEcCtD
Orlistat—Convulsion—Methylprednisolone—atopic dermatitis	0.000127	0.00062	CcSEcCtD
Orlistat—Infection—Hydrocortisone—atopic dermatitis	0.000126	0.000618	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000126	0.000615	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—SELE—atopic dermatitis	0.000126	0.00137	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL22—atopic dermatitis	0.000126	0.00137	CbGpPWpGaD
Orlistat—Myalgia—Triamcinolone—atopic dermatitis	0.000125	0.000611	CcSEcCtD
Orlistat—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000125	0.00061	CcSEcCtD
Orlistat—Myalgia—Methylprednisolone—atopic dermatitis	0.000125	0.000609	CcSEcCtD
Orlistat—Anxiety—Methylprednisolone—atopic dermatitis	0.000124	0.000607	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000124	0.000605	CcSEcCtD
Orlistat—Skin disorder—Hydrocortisone—atopic dermatitis	0.000124	0.000604	CcSEcCtD
Orlistat—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000124	0.000604	CcSEcCtD
Orlistat—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000124	0.000604	CcSEcCtD
Orlistat—Discomfort—Triamcinolone—atopic dermatitis	0.000123	0.000603	CcSEcCtD
Orlistat—Discomfort—Methylprednisolone—atopic dermatitis	0.000123	0.000602	CcSEcCtD
Orlistat—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000123	0.000601	CcSEcCtD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000123	0.00134	CbGpPWpGaD
Orlistat—Dry mouth—Triamcinolone—atopic dermatitis	0.000122	0.000597	CcSEcCtD
Orlistat—Angioedema—Dexamethasone—atopic dermatitis	0.000122	0.000595	CcSEcCtD
Orlistat—Angioedema—Betamethasone—atopic dermatitis	0.000122	0.000595	CcSEcCtD
Orlistat—Nausea—Tacrolimus—atopic dermatitis	0.000121	0.000592	CcSEcCtD
Orlistat—Immune system disorder—Prednisone—atopic dermatitis	0.00012	0.000588	CcSEcCtD
Orlistat—Malaise—Betamethasone—atopic dermatitis	0.00012	0.000587	CcSEcCtD
Orlistat—Malaise—Dexamethasone—atopic dermatitis	0.00012	0.000587	CcSEcCtD
Orlistat—Oedema—Triamcinolone—atopic dermatitis	0.00012	0.000585	CcSEcCtD
Orlistat—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00012	0.000585	CcSEcCtD
Orlistat—Vertigo—Dexamethasone—atopic dermatitis	0.00012	0.000585	CcSEcCtD
Orlistat—Vertigo—Betamethasone—atopic dermatitis	0.00012	0.000585	CcSEcCtD
Orlistat—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.00012	0.000584	CcSEcCtD
Orlistat—Infection—Triamcinolone—atopic dermatitis	0.000119	0.000582	CcSEcCtD
Orlistat—Infection—Methylprednisolone—atopic dermatitis	0.000119	0.00058	CcSEcCtD
Orlistat—Insomnia—Prednisolone—atopic dermatitis	0.000118	0.000576	CcSEcCtD
Orlistat—Alopecia—Prednisone—atopic dermatitis	0.000118	0.000575	CcSEcCtD
Orlistat—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000117	0.000573	CcSEcCtD
Orlistat—Paraesthesia—Prednisolone—atopic dermatitis	0.000117	0.000572	CcSEcCtD
Orlistat—Mental disorder—Prednisone—atopic dermatitis	0.000117	0.00057	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000116	0.00127	CbGpPWpGaD
Orlistat—Skin disorder—Methylprednisolone—atopic dermatitis	0.000116	0.000567	CcSEcCtD
Orlistat—Malnutrition—Prednisone—atopic dermatitis	0.000116	0.000567	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000116	0.000566	CcSEcCtD
Orlistat—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000116	0.000566	CcSEcCtD
Orlistat—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000116	0.000565	CcSEcCtD
Orlistat—Convulsion—Betamethasone—atopic dermatitis	0.000115	0.000564	CcSEcCtD
Orlistat—Convulsion—Dexamethasone—atopic dermatitis	0.000115	0.000564	CcSEcCtD
Orlistat—PLA2G4A—Dexamethasone—Mometasone—atopic dermatitis	0.000115	0.0204	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Mometasone—atopic dermatitis	0.000115	0.0204	CbGdCrCtD
Orlistat—Insomnia—Hydrocortisone—atopic dermatitis	0.000115	0.000562	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—TAC1—atopic dermatitis	0.000114	0.00125	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NPS—atopic dermatitis	0.000114	0.00125	CbGpPWpGaD
Orlistat—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000114	0.000558	CcSEcCtD
Orlistat—Myalgia—Dexamethasone—atopic dermatitis	0.000113	0.000554	CcSEcCtD
Orlistat—Myalgia—Betamethasone—atopic dermatitis	0.000113	0.000554	CcSEcCtD
Orlistat—Anxiety—Betamethasone—atopic dermatitis	0.000113	0.000552	CcSEcCtD
Orlistat—Anxiety—Dexamethasone—atopic dermatitis	0.000113	0.000552	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CXCR3—atopic dermatitis	0.000112	0.00123	CbGpPWpGaD
Orlistat—Discomfort—Betamethasone—atopic dermatitis	0.000112	0.000547	CcSEcCtD
Orlistat—Discomfort—Dexamethasone—atopic dermatitis	0.000112	0.000547	CcSEcCtD
Orlistat—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000112	0.000547	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—CCL27—atopic dermatitis	0.000112	0.00122	CbGpPWpGaD
Orlistat—Pain—Prednisolone—atopic dermatitis	0.000111	0.000544	CcSEcCtD
Orlistat—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000111	0.00054	CcSEcCtD
Orlistat—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00011	0.000537	CcSEcCtD
Orlistat—Fatigue—Hydrocortisone—atopic dermatitis	0.00011	0.000536	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—CXCL10—atopic dermatitis	0.000109	0.0012	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL10—atopic dermatitis	0.000109	0.0012	CbGpPWpGaD
Orlistat—Vision blurred—Prednisone—atopic dermatitis	0.000109	0.000534	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000109	0.000533	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000109	0.000532	CcSEcCtD
Orlistat—Pain—Hydrocortisone—atopic dermatitis	0.000109	0.000532	CcSEcCtD
Orlistat—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000109	0.000531	CcSEcCtD
Orlistat—Oedema—Dexamethasone—atopic dermatitis	0.000109	0.000531	CcSEcCtD
Orlistat—Oedema—Betamethasone—atopic dermatitis	0.000109	0.000531	CcSEcCtD
Orlistat—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000109	0.000531	CcSEcCtD
Orlistat—Insomnia—Triamcinolone—atopic dermatitis	0.000108	0.000529	CcSEcCtD
Orlistat—Insomnia—Methylprednisolone—atopic dermatitis	0.000108	0.000528	CcSEcCtD
Orlistat—Infection—Dexamethasone—atopic dermatitis	0.000108	0.000528	CcSEcCtD
Orlistat—Infection—Betamethasone—atopic dermatitis	0.000108	0.000528	CcSEcCtD
Orlistat—Ill-defined disorder—Prednisone—atopic dermatitis	0.000108	0.000526	CcSEcCtD
Orlistat—Paraesthesia—Triamcinolone—atopic dermatitis	0.000108	0.000526	CcSEcCtD
Orlistat—Feeling abnormal—Prednisolone—atopic dermatitis	0.000107	0.000525	CcSEcCtD
Orlistat—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000107	0.000525	CcSEcCtD
Orlistat—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000107	0.000521	CcSEcCtD
Orlistat—Nervous system disorder—Betamethasone—atopic dermatitis	0.000107	0.000521	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—IL5—atopic dermatitis	0.000106	0.00116	CbGpPWpGaD
Orlistat—Angioedema—Prednisone—atopic dermatitis	0.000106	0.000518	CcSEcCtD
Orlistat—Dyspepsia—Triamcinolone—atopic dermatitis	0.000105	0.000515	CcSEcCtD
Orlistat—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000105	0.000514	CcSEcCtD
Orlistat—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000105	0.000514	CcSEcCtD
Orlistat—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000105	0.000514	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000105	0.00115	CbGpPWpGaD
Orlistat—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000105	0.000512	CcSEcCtD
Orlistat—Malaise—Prednisone—atopic dermatitis	0.000105	0.000511	CcSEcCtD
Orlistat—Vertigo—Prednisone—atopic dermatitis	0.000104	0.000509	CcSEcCtD
Orlistat—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000104	0.000508	CcSEcCtD
Orlistat—Urticaria—Prednisolone—atopic dermatitis	0.000103	0.000506	CcSEcCtD
Orlistat—Fatigue—Triamcinolone—atopic dermatitis	0.000103	0.000505	CcSEcCtD
Orlistat—Fatigue—Methylprednisolone—atopic dermatitis	0.000103	0.000504	CcSEcCtD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	0.000102	0.00112	CbGpPWpGaD
Orlistat—Pain—Triamcinolone—atopic dermatitis	0.000102	0.000501	CcSEcCtD
Orlistat—Urticaria—Hydrocortisone—atopic dermatitis	0.000101	0.000494	CcSEcCtD
Orlistat—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000101	0.000491	CcSEcCtD
Orlistat—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000101	0.000491	CcSEcCtD
Orlistat—Convulsion—Prednisone—atopic dermatitis	0.0001	0.000491	CcSEcCtD
Orlistat—PNLIP—Disease—CCR5—atopic dermatitis	0.0001	0.0011	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL17—atopic dermatitis	0.0001	0.0011	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	9.9e-05	0.000484	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	9.9e-05	0.000484	CcSEcCtD
Orlistat—Myalgia—Prednisone—atopic dermatitis	9.87e-05	0.000483	CcSEcCtD
Orlistat—Feeling abnormal—Triamcinolone—atopic dermatitis	9.87e-05	0.000482	CcSEcCtD
Orlistat—Feeling abnormal—Methylprednisolone—atopic dermatitis	9.85e-05	0.000481	CcSEcCtD
Orlistat—Anxiety—Prednisone—atopic dermatitis	9.84e-05	0.000481	CcSEcCtD
Orlistat—Insomnia—Dexamethasone—atopic dermatitis	9.83e-05	0.00048	CcSEcCtD
Orlistat—Insomnia—Betamethasone—atopic dermatitis	9.83e-05	0.00048	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	9.81e-05	0.000479	CcSEcCtD
Orlistat—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	9.77e-05	0.000478	CcSEcCtD
Orlistat—Paraesthesia—Dexamethasone—atopic dermatitis	9.76e-05	0.000477	CcSEcCtD
Orlistat—Paraesthesia—Betamethasone—atopic dermatitis	9.76e-05	0.000477	CcSEcCtD
Orlistat—Discomfort—Prednisone—atopic dermatitis	9.75e-05	0.000477	CcSEcCtD
Orlistat—Hypersensitivity—Prednisolone—atopic dermatitis	9.6e-05	0.000469	CcSEcCtD
Orlistat—Dyspepsia—Betamethasone—atopic dermatitis	9.57e-05	0.000468	CcSEcCtD
Orlistat—Dyspepsia—Dexamethasone—atopic dermatitis	9.57e-05	0.000468	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—CXCL8—atopic dermatitis	9.56e-05	0.00105	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL8—atopic dermatitis	9.56e-05	0.00105	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL5—atopic dermatitis	9.52e-05	0.00104	CbGpPWpGaD
Orlistat—Urticaria—Triamcinolone—atopic dermatitis	9.52e-05	0.000465	CcSEcCtD
Orlistat—Urticaria—Methylprednisolone—atopic dermatitis	9.49e-05	0.000464	CcSEcCtD
Orlistat—Body temperature increased—Triamcinolone—atopic dermatitis	9.47e-05	0.000463	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisone—atopic dermatitis	9.46e-05	0.000463	CcSEcCtD
Orlistat—Oedema—Prednisone—atopic dermatitis	9.46e-05	0.000463	CcSEcCtD
Orlistat—Abdominal pain—Methylprednisolone—atopic dermatitis	9.45e-05	0.000462	CcSEcCtD
Orlistat—Decreased appetite—Betamethasone—atopic dermatitis	9.45e-05	0.000462	CcSEcCtD
Orlistat—Decreased appetite—Dexamethasone—atopic dermatitis	9.45e-05	0.000462	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—CCL5—atopic dermatitis	9.42e-05	0.00103	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL5—atopic dermatitis	9.42e-05	0.00103	CbGpPWpGaD
Orlistat—Infection—Prednisone—atopic dermatitis	9.4e-05	0.00046	CcSEcCtD
Orlistat—Gastrointestinal disorder—Betamethasone—atopic dermatitis	9.38e-05	0.000459	CcSEcCtD
Orlistat—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	9.38e-05	0.000459	CcSEcCtD
Orlistat—Hypersensitivity—Hydrocortisone—atopic dermatitis	9.37e-05	0.000458	CcSEcCtD
Orlistat—Fatigue—Dexamethasone—atopic dermatitis	9.37e-05	0.000458	CcSEcCtD
Orlistat—Fatigue—Betamethasone—atopic dermatitis	9.37e-05	0.000458	CcSEcCtD
Orlistat—Pain—Dexamethasone—atopic dermatitis	9.29e-05	0.000454	CcSEcCtD
Orlistat—Pain—Betamethasone—atopic dermatitis	9.29e-05	0.000454	CcSEcCtD
Orlistat—Nervous system disorder—Prednisone—atopic dermatitis	9.28e-05	0.000454	CcSEcCtD
Orlistat—Skin disorder—Prednisone—atopic dermatitis	9.19e-05	0.000449	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisone—atopic dermatitis	9.15e-05	0.000447	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—IL2—atopic dermatitis	9.14e-05	0.001	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—IL2—atopic dermatitis	9.14e-05	0.001	CbGpPWpGaD
Orlistat—Asthenia—Hydrocortisone—atopic dermatitis	9.13e-05	0.000446	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CXCL10—atopic dermatitis	9.06e-05	0.000992	CbGpPWpGaD
Orlistat—Pruritus—Hydrocortisone—atopic dermatitis	9e-05	0.00044	CcSEcCtD
Orlistat—Feeling abnormal—Betamethasone—atopic dermatitis	8.96e-05	0.000438	CcSEcCtD
Orlistat—Feeling abnormal—Dexamethasone—atopic dermatitis	8.96e-05	0.000438	CcSEcCtD
Orlistat—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.89e-05	0.000434	CcSEcCtD
Orlistat—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.89e-05	0.000434	CcSEcCtD
Orlistat—Hypersensitivity—Triamcinolone—atopic dermatitis	8.82e-05	0.000431	CcSEcCtD
Orlistat—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.81e-05	0.00043	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—NGF—atopic dermatitis	8.72e-05	0.000954	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NGF—atopic dermatitis	8.72e-05	0.000954	CbGpPWpGaD
Orlistat—Diarrhoea—Hydrocortisone—atopic dermatitis	8.7e-05	0.000425	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—CXCL8—atopic dermatitis	8.68e-05	0.00095	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL8—atopic dermatitis	8.68e-05	0.00095	CbGpPWpGaD
Orlistat—Urticaria—Dexamethasone—atopic dermatitis	8.63e-05	0.000422	CcSEcCtD
Orlistat—Urticaria—Betamethasone—atopic dermatitis	8.63e-05	0.000422	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Prednisone—atopic dermatitis	8.62e-05	0.000421	CcSEcCtD
Orlistat—Dizziness—Prednisolone—atopic dermatitis	8.61e-05	0.000421	CcSEcCtD
Orlistat—Asthenia—Triamcinolone—atopic dermatitis	8.59e-05	0.00042	CcSEcCtD
Orlistat—Abdominal pain—Betamethasone—atopic dermatitis	8.59e-05	0.00042	CcSEcCtD
Orlistat—Body temperature increased—Dexamethasone—atopic dermatitis	8.59e-05	0.00042	CcSEcCtD
Orlistat—Body temperature increased—Betamethasone—atopic dermatitis	8.59e-05	0.00042	CcSEcCtD
Orlistat—Abdominal pain—Dexamethasone—atopic dermatitis	8.59e-05	0.00042	CcSEcCtD
Orlistat—Asthenia—Methylprednisolone—atopic dermatitis	8.57e-05	0.000419	CcSEcCtD
Orlistat—Insomnia—Prednisone—atopic dermatitis	8.56e-05	0.000418	CcSEcCtD
Orlistat—Paraesthesia—Prednisone—atopic dermatitis	8.5e-05	0.000415	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—CCR5—atopic dermatitis	8.48e-05	0.000928	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCR5—atopic dermatitis	8.48e-05	0.000928	CbGpPWpGaD
Orlistat—Pruritus—Triamcinolone—atopic dermatitis	8.47e-05	0.000414	CcSEcCtD
Orlistat—Pruritus—Methylprednisolone—atopic dermatitis	8.46e-05	0.000413	CcSEcCtD
Orlistat—Dizziness—Hydrocortisone—atopic dermatitis	8.41e-05	0.000411	CcSEcCtD
Orlistat—Dyspepsia—Prednisone—atopic dermatitis	8.33e-05	0.000407	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—IL2—atopic dermatitis	8.3e-05	0.000908	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL2—atopic dermatitis	8.3e-05	0.000908	CbGpPWpGaD
Orlistat—Decreased appetite—Prednisone—atopic dermatitis	8.23e-05	0.000402	CcSEcCtD
Orlistat—Rash—Prednisolone—atopic dermatitis	8.21e-05	0.000401	CcSEcCtD
Orlistat—Dermatitis—Prednisolone—atopic dermatitis	8.2e-05	0.000401	CcSEcCtD
Orlistat—Diarrhoea—Methylprednisolone—atopic dermatitis	8.18e-05	0.0004	CcSEcCtD
Orlistat—Fatigue—Prednisone—atopic dermatitis	8.16e-05	0.000399	CcSEcCtD
Orlistat—Headache—Prednisolone—atopic dermatitis	8.16e-05	0.000399	CcSEcCtD
Orlistat—Vomiting—Hydrocortisone—atopic dermatitis	8.09e-05	0.000395	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—CCL11—atopic dermatitis	8.09e-05	0.000885	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARA—atopic dermatitis	8.06e-05	0.000882	CbGpPWpGaD
Orlistat—Rash—Hydrocortisone—atopic dermatitis	8.02e-05	0.000392	CcSEcCtD
Orlistat—Dermatitis—Hydrocortisone—atopic dermatitis	8.01e-05	0.000392	CcSEcCtD
Orlistat—PLA2G4A—Signaling Pathways—FCER2—atopic dermatitis	7.98e-05	0.000873	CbGpPWpGaD
Orlistat—Headache—Hydrocortisone—atopic dermatitis	7.97e-05	0.000389	CcSEcCtD
Orlistat—Dizziness—Triamcinolone—atopic dermatitis	7.92e-05	0.000387	CcSEcCtD
Orlistat—Dizziness—Methylprednisolone—atopic dermatitis	7.9e-05	0.000386	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CCL5—atopic dermatitis	7.8e-05	0.000854	CbGpPWpGaD
Orlistat—Feeling abnormal—Prednisone—atopic dermatitis	7.8e-05	0.000381	CcSEcCtD
Orlistat—Asthenia—Dexamethasone—atopic dermatitis	7.8e-05	0.000381	CcSEcCtD
Orlistat—Asthenia—Betamethasone—atopic dermatitis	7.8e-05	0.000381	CcSEcCtD
Orlistat—Gastrointestinal pain—Prednisone—atopic dermatitis	7.74e-05	0.000378	CcSEcCtD
Orlistat—Nausea—Prednisolone—atopic dermatitis	7.74e-05	0.000378	CcSEcCtD
Orlistat—Pruritus—Dexamethasone—atopic dermatitis	7.69e-05	0.000376	CcSEcCtD
Orlistat—Pruritus—Betamethasone—atopic dermatitis	7.69e-05	0.000376	CcSEcCtD
Orlistat—Vomiting—Triamcinolone—atopic dermatitis	7.62e-05	0.000372	CcSEcCtD
Orlistat—Vomiting—Methylprednisolone—atopic dermatitis	7.6e-05	0.000371	CcSEcCtD
Orlistat—Nausea—Hydrocortisone—atopic dermatitis	7.56e-05	0.000369	CcSEcCtD
Orlistat—Rash—Triamcinolone—atopic dermatitis	7.55e-05	0.000369	CcSEcCtD
Orlistat—Dermatitis—Triamcinolone—atopic dermatitis	7.55e-05	0.000369	CcSEcCtD
Orlistat—PLA2G4A—Metabolism—GLB1—atopic dermatitis	7.54e-05	0.000825	CbGpPWpGaD
Orlistat—Rash—Methylprednisolone—atopic dermatitis	7.54e-05	0.000368	CcSEcCtD
Orlistat—Dermatitis—Methylprednisolone—atopic dermatitis	7.53e-05	0.000368	CcSEcCtD
Orlistat—Urticaria—Prednisone—atopic dermatitis	7.52e-05	0.000367	CcSEcCtD
Orlistat—Headache—Triamcinolone—atopic dermatitis	7.5e-05	0.000367	CcSEcCtD
Orlistat—Headache—Methylprednisolone—atopic dermatitis	7.49e-05	0.000366	CcSEcCtD
Orlistat—Body temperature increased—Prednisone—atopic dermatitis	7.48e-05	0.000366	CcSEcCtD
Orlistat—Abdominal pain—Prednisone—atopic dermatitis	7.48e-05	0.000366	CcSEcCtD
Orlistat—Diarrhoea—Dexamethasone—atopic dermatitis	7.44e-05	0.000363	CcSEcCtD
Orlistat—Diarrhoea—Betamethasone—atopic dermatitis	7.44e-05	0.000363	CcSEcCtD
Orlistat—PLA2G4A—Signaling Pathways—CCL22—atopic dermatitis	7.41e-05	0.000811	CbGpPWpGaD
Orlistat—PLA2G4A—Dexamethasone—Hydrocortisone—atopic dermatitis	7.3e-05	0.0129	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Hydrocortisone—atopic dermatitis	7.3e-05	0.0129	CbGdCrCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	7.3e-05	0.000799	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADSL—atopic dermatitis	7.23e-05	0.000791	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NGF—atopic dermatitis	7.23e-05	0.000791	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NFKBIA—atopic dermatitis	7.19e-05	0.000787	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NFKBIA—atopic dermatitis	7.19e-05	0.000787	CbGpPWpGaD
Orlistat—Dizziness—Betamethasone—atopic dermatitis	7.19e-05	0.000351	CcSEcCtD
Orlistat—Dizziness—Dexamethasone—atopic dermatitis	7.19e-05	0.000351	CcSEcCtD
Orlistat—Nausea—Triamcinolone—atopic dermatitis	7.11e-05	0.000348	CcSEcCtD
Orlistat—FASN—Disease—CCR5—atopic dermatitis	7.1e-05	0.000777	CbGpPWpGaD
Orlistat—Nausea—Methylprednisolone—atopic dermatitis	7.1e-05	0.000347	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	7.06e-05	0.000772	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCR5—atopic dermatitis	7.03e-05	0.000769	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisone—atopic dermatitis	6.97e-05	0.000341	CcSEcCtD
Orlistat—Vomiting—Betamethasone—atopic dermatitis	6.91e-05	0.000338	CcSEcCtD
Orlistat—Vomiting—Dexamethasone—atopic dermatitis	6.91e-05	0.000338	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Methylprednisolone—atopic dermatitis	6.89e-05	0.0122	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Methylprednisolone—atopic dermatitis	6.89e-05	0.0122	CbGdCrCtD
Orlistat—Rash—Betamethasone—atopic dermatitis	6.85e-05	0.000335	CcSEcCtD
Orlistat—Rash—Dexamethasone—atopic dermatitis	6.85e-05	0.000335	CcSEcCtD
Orlistat—Dermatitis—Dexamethasone—atopic dermatitis	6.85e-05	0.000335	CcSEcCtD
Orlistat—Dermatitis—Betamethasone—atopic dermatitis	6.85e-05	0.000335	CcSEcCtD
Orlistat—Headache—Dexamethasone—atopic dermatitis	6.81e-05	0.000333	CcSEcCtD
Orlistat—Headache—Betamethasone—atopic dermatitis	6.81e-05	0.000333	CcSEcCtD
Orlistat—Asthenia—Prednisone—atopic dermatitis	6.79e-05	0.000332	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Dexamethasone—atopic dermatitis	6.78e-05	0.012	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Betamethasone—atopic dermatitis	6.78e-05	0.012	CbGdCrCtD
Orlistat—Pruritus—Prednisone—atopic dermatitis	6.7e-05	0.000327	CcSEcCtD
Orlistat—PLA2G4A—Dexamethasone—Triamcinolone—atopic dermatitis	6.63e-05	0.0117	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Triamcinolone—atopic dermatitis	6.63e-05	0.0117	CbGdCrCtD
Orlistat—PLA2G4A—Signaling Pathways—CCL27—atopic dermatitis	6.61e-05	0.000723	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCR3—atopic dermatitis	6.59e-05	0.000721	CbGpPWpGaD
Orlistat—Diarrhoea—Prednisone—atopic dermatitis	6.48e-05	0.000317	CcSEcCtD
Orlistat—Nausea—Betamethasone—atopic dermatitis	6.46e-05	0.000316	CcSEcCtD
Orlistat—Nausea—Dexamethasone—atopic dermatitis	6.46e-05	0.000316	CcSEcCtD
Orlistat—PNLIP—Disease—CD4—atopic dermatitis	6.3e-05	0.00069	CbGpPWpGaD
Orlistat—PLA2G4A—Dexamethasone—Prednisone—atopic dermatitis	6.29e-05	0.0111	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Prednisone—atopic dermatitis	6.29e-05	0.0111	CbGdCrCtD
Orlistat—Dizziness—Prednisone—atopic dermatitis	6.26e-05	0.000306	CcSEcCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisolone—atopic dermatitis	6.14e-05	0.0108	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Prednisolone—atopic dermatitis	6.14e-05	0.0108	CbGdCrCtD
Orlistat—Vomiting—Prednisone—atopic dermatitis	6.02e-05	0.000294	CcSEcCtD
Orlistat—Rash—Prednisone—atopic dermatitis	5.97e-05	0.000292	CcSEcCtD
Orlistat—Dermatitis—Prednisone—atopic dermatitis	5.96e-05	0.000291	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—NFKBIA—atopic dermatitis	5.96e-05	0.000652	CbGpPWpGaD
Orlistat—Headache—Prednisone—atopic dermatitis	5.93e-05	0.00029	CcSEcCtD
Orlistat—PLA2G4A—Signaling Pathways—CCL17—atopic dermatitis	5.93e-05	0.000649	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NPS—atopic dermatitis	5.88e-05	0.000643	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TAC1—atopic dermatitis	5.88e-05	0.000643	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.78e-05	0.000632	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCR3—atopic dermatitis	5.76e-05	0.000631	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARA—atopic dermatitis	5.7e-05	0.000624	CbGpPWpGaD
Orlistat—Nausea—Prednisone—atopic dermatitis	5.62e-05	0.000275	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.49e-05	0.000601	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL5—atopic dermatitis	5.46e-05	0.000598	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KIF3A—atopic dermatitis	5.28e-05	0.000578	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—atopic dermatitis	5.13e-05	0.000561	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—atopic dermatitis	5.13e-05	0.000561	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL2—atopic dermatitis	4.9e-05	0.000536	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL2—atopic dermatitis	4.9e-05	0.000536	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—atopic dermatitis	4.88e-05	0.000534	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—atopic dermatitis	4.88e-05	0.000534	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CMA1—atopic dermatitis	4.78e-05	0.000523	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL11—atopic dermatitis	4.78e-05	0.000523	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL10—atopic dermatitis	4.66e-05	0.00051	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAPK8—atopic dermatitis	4.51e-05	0.000494	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAPK8—atopic dermatitis	4.51e-05	0.000494	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STAT6—atopic dermatitis	4.49e-05	0.000492	CbGpPWpGaD
Orlistat—FASN—Disease—CD4—atopic dermatitis	4.46e-05	0.000488	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—atopic dermatitis	4.25e-05	0.000465	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL2—atopic dermatitis	4.06e-05	0.000444	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL5—atopic dermatitis	4.01e-05	0.000439	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCR3—atopic dermatitis	3.89e-05	0.000426	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAPK8—atopic dermatitis	3.74e-05	0.000409	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL2—atopic dermatitis	3.64e-05	0.000398	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCR5—atopic dermatitis	3.61e-05	0.000395	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TAC1—atopic dermatitis	3.47e-05	0.00038	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NPS—atopic dermatitis	3.47e-05	0.00038	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—atopic dermatitis	3.41e-05	0.000373	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCR3—atopic dermatitis	3.4e-05	0.000372	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL5—atopic dermatitis	3.23e-05	0.000353	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—atopic dermatitis	2.88e-05	0.000315	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—atopic dermatitis	2.88e-05	0.000315	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL10—atopic dermatitis	2.75e-05	0.000301	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARA—atopic dermatitis	2.45e-05	0.000268	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—atopic dermatitis	2.41e-05	0.000264	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—atopic dermatitis	2.39e-05	0.000261	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL5—atopic dermatitis	2.37e-05	0.000259	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NGF—atopic dermatitis	2.19e-05	0.00024	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—atopic dermatitis	2.18e-05	0.000239	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCR5—atopic dermatitis	2.13e-05	0.000233	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL2—atopic dermatitis	2.09e-05	0.000228	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NFKBIA—atopic dermatitis	1.81e-05	0.000198	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.77e-05	0.000193	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.69e-05	0.000185	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—atopic dermatitis	1.29e-05	0.000141	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL2—atopic dermatitis	1.23e-05	0.000135	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—atopic dermatitis	1.23e-05	0.000134	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK8—atopic dermatitis	1.13e-05	0.000124	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—atopic dermatitis	7.25e-06	7.93e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARA—atopic dermatitis	5.73e-06	6.27e-05	CbGpPWpGaD
